Literature DB >> 29192717

In vitro trials of a wearable artificial kidney (WAK).

Nikolai A Bazaev1, Nataliya I Dorofeeva1, Nikita M Zhilo1, Evgeniy V Streltsov1.   

Abstract

BACKGROUND: This paper presents results of in vitro trials of a wearable artificial kidney (WAK).
MATERIALS AND METHODS: To carry out the trials, a test bench was developed. It consisted of a patient imitator, a tubing set and measuring equipment.
RESULTS: Our WAK can eliminate urea, uric acid and creatinine from spent dialysate with mean mass rates of 0.85 ± 0.1 g/h, 0.10 ± 0.04 g/h and 0.05 ± 0.01 g/h, respectively. Concentrations of Na+, Cl- and Ca2+ ions were kept in the 10% range from initial values. We demonstrated that our WAK can operate for 38 hours without having to replace expendable materials.
CONCLUSIONS: The WAK that we developed can eliminate metabolites from spent dialysis fluid with mass rates that are sufficient to maintain stable, physiologically normal metabolite concentrations in patients' blood.

Entities:  

Year:  2017        PMID: 29192717     DOI: 10.5301/ijao.5000651

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  1 in total

1.  Second Generation Nanoporous Silicon Nitride Membranes for High Toxin Clearance and Small Format Hemodialysis.

Authors:  Kayli Hill; Samuel N Walker; Alec Salminen; Hung L Chung; Xunzhi Li; Bahie Ezzat; Joshua J Miller; Jon-Paul S DesOrmeaux; Jingkai Zhang; Andrew Hayden; Tucker Burgin; Lindsay Piraino; Marina N May; Thomas R Gaborski; James A Roussie; Jeremy Taylor; Louis DiVincenti; Alexander A Shestopalov; James L McGrath; Dean G Johnson
Journal:  Adv Healthc Mater       Date:  2020-01-15       Impact factor: 9.933

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.